Bioavailability and Bioactivity of Red Wine Melatonin in Humans
Wine-MLT
Serum and Salivary Melatonin Levels and Antioxidant Power of Melatonin-rich Red Wine
1 other identifier
interventional
12
1 country
1
Brief Summary
Melatonin (MLT) is a bioactive compound in red wine. The investigators will investigate the serum and salivary concentrations and antioxidant power of MLT after the intake of a glass of red wine. Twelve healthy volunteers were recruited to receive both 125 mL of red wine rich in MLT (10 ng mL-1) and without MLT (placebo), via a randomized, cross-over, and double-blind design. Serum and salivary MLT will be measured by liquid chromatography coupled to mass spectrometry (LC-MS) and enzyme-linked immunosorbent (ELISA), respectively. The ferric ion reducing antioxidant power (FRAP) will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 30, 2016
CompletedFirst Posted
Study publicly available on registry
May 10, 2016
CompletedMay 10, 2016
May 1, 2016
8 months
April 30, 2016
May 5, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum and salivary melatonin after red wine intake (with or without MLT)
LC-MS analyses for serum and ELISA analyses for saliva
Time-course of the serum melatonin levels in healthy volunteer from 0 min to 90 min after administration of red wine. Time-course of the salivary melatonin levels in healthy volunteer from 0 min to 120 min after administration of red wine.
Secondary Outcomes (1)
Antioxidant power of saliva and serum after red wine intake (with or without MLT)
Time-course of the serum antioxidant power in healthy volunteer from 0 min to 90 min after administration of red wine. Time-course of the salivary antioxidant power in healthy volunteer from 0 min to 120 min after administration of red wine.
Other Outcomes (1)
Adverse effects
Acute side effects during the trial recorded at each experimental day each experimental day, up to 1 day after
Study Arms (2)
Red wine with Melatonin
EXPERIMENTALRosso di Marco is a wine without MLT (previous screening). This wine will be enriched with 10 ng mL-1 MLT (MLT+) and used as experimental wine.
Red wine without Melatonin
PLACEBO COMPARATORRosso di Marco is a wine without MLT (previous screening). This wine will be used as placebo treatment (PLC).
Interventions
Twelve healthy volunteers will be recruited to receive both 125 mL of red wine rich in MLT (10 ng mL-1)
Twelve healthy volunteers will be recruited to receive both 125 mL of red wine without MLT
Eligibility Criteria
You may qualify if:
- to be healthy
- to have normal weight (BMI 18.5-25.0)
- to voluntarily accept to participate to the study.
You may not qualify if:
- pregnancy and lactation for women;
- supplementation with MLT and/or any other dietary supplement (vitamins, antioxidants, botanicals, phytochemicals)
- systemic and chronic-degenerative diseases
- abnormal hematological parameters
- heavy smoking and alcohol drinking
- high-intensity physical activity
- under pharmacological treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Milan
Milan, Italy, 20142, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 30, 2016
First Posted
May 10, 2016
Study Start
July 1, 2014
Primary Completion
March 1, 2015
Study Completion
July 1, 2015
Last Updated
May 10, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share